Home›Stock Screener›Vivanza Biosciences

Vivanza Biosciences Share Price Today | Stock Price & Vivanza Biosciences Share Screener

VIVANZA Pharmaceuticals & Biotechnology
Live Share Price BSE
₹1.40
▼ -0.02 (-1.41%)
2026-11-18 00:00:00

As of November 18, 2026, the live Vivanza Biosciences share price (BSE: VIVANZA) is ₹1.40, down 1.41% from the previous close, with shares trading between ₹1.31 and ₹1.50 in today's trading session, and a 52-week range of ₹1.36–₹2.40. Track Vivanza Biosciences marketcap in USD to gauge the company's total market size. Use the Vivanza Biosciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vivanza Biosciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Vivanza Biosciences Market Cap ₹5.70 Cr.
VIVANZA P/E Ratio (TTM) 142.00
Vivanza Biosciences P/B Ratio 1.22
EPS (TTM) ₹0.10
Dividend Yield -
Debt to Equity 2.26
VIVANZA 52 Week High ₹2.40
Vivanza Biosciences 52 Week Low ₹1.36
Operating Margin 2.00%
Profit Margin -
VIVANZA Revenue (TTM) ₹11.00
EBITDA -
Net Income -
Total Assets ₹22.00
Total Equity ₹4.00

Vivanza Biosciences Share Price Chart

Track the current stock price of Vivanza Biosciences with an interactive chart. Analyse VIVANZA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vivanza Biosciences stock quote in one place.

The quote of ₹1.40 sits between the 52-week low of ₹1.36 and the 52-week high of ₹2.40, and the latest session moved -1.41% from the previous close.

Vivanza Biosciences Company Profile - Fundamental Screener

Screen Vivanza Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIVANZA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE984E01035.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE984E01035

Vivanza Biosciences Balance Sheet Screener

Screen VIVANZA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹22, up from ₹17 in 2025.

Latest statistics put total assets at ₹22 and shareholder funds at ₹4, with a leverage ratio of 2.26.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 22 17 20 23 16 8 12 11 10 7
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 2 2 2 2 2 2 2 2 2 2

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 3 3 1 3 0 0 1 1 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4 4 5 4 4 3 3 3 4 4
Share Capital 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 0 0 1 0 -1 -1 -1 -1 0 -1

Vivanza Biosciences Income Statement Screener - Profit & Revenue Analysis

Screen Vivanza Biosciences income statement and profit fundamentals. Analyze VIVANZA quarterly results. Vivanza Biosciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹11 and net profit was ₹0, equal to earnings per unit of ₹0.03, at an operating margin of 2%.

In that period expenses were ₹11, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹10 and net profit of ₹0.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 11 10 6 45 55 9 1 2 3 2 4 7 8 9 8
Expenses 11 9 7 45 55 9 1 1 3 2 5 6 7 9 8

Operating Costs and Margins

EBITDA 0 0 0 0 1 0 -1 0 0 0 0 0 0 1 0
Operating Profit % 2.00% -1.00% -4.00% 0.00% 1.00% 2.00% -200.00% 8.00% 4.00% 15.00% -3.00% 4.00% 4.00% 6.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 1 0 -1 0 0 0 0 0 0 1 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 1 0 -1 0 0 0 0 0 0 1 0
EPS 0.03 0.04 -0.11 0.05 0.14 0.02 -0.25 0.01 0.00 0.07 -0.10 0.05 0.07 0.12 -0.26

Vivanza Biosciences Cash Flow Screener - Liquidity Fundamentals

Screen VIVANZA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹3.

Over the same period, investing activities provided ₹0 and financing activities provided ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -3 -3 2 -1 3 -3 3 1 0 -2
Investing Activities 0 0 0 0 0 0 0 0 0 2

Financing and Net Cash

Financing Activities 3 3 -2 1 -3 3 -3 -1 -1 0
Net Cash Flow 0 0 0 0 0 0 0 0 -1 0

Vivanza Biosciences Shareholding Pattern Screener

See Vivanza Biosciences shareholding pattern with promoter, FII, and DII holdings. Check Vivanza Biosciences promoter holding and ownership changes for VIVANZA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 20.02%, foreign institutions 0.00%, domestic institutions 0.00% and the public 73.34%, spread across 19,461 shareholders.

The shareholder count was 19,461 in 2026-Mar, compared with 19,254 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 20.02% 20.02% 20.02% 20.02% 20.02% 20.02% 20.02% 43.24%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 73.34% 73.49% 73.90% 73.69% 73.36% 73.34% 73.42% 13.82%
Other Holding 6.64% 6.49% 6.07% 6.29% 6.62% 6.64% 6.56% 42.94%
Shareholder Count 19,461 19,254 19,366 20,833 20,458 20,170 19,822 6,992

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vivanza Biosciences. Vivanza Biosciences dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Vivanza Biosciences.

Vivanza Biosciences Stock Index Membership - Nifty & Sensex

See which indices include Vivanza Biosciences stock. Check VIVANZA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Vivanza Biosciences is not part of any tracked indices.
Only major market indices are tracked in our system.

Vivanza Biosciences Market Events Screener - Corporate Actions

Get Vivanza Biosciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vivanza Biosciences stock events that may affect VIVANZA share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 6, 2026, with a record date of November 6, 2026.

It is followed by Annual General Meeting dated September 11, 2026 and Quarterly Result Announcement dated August 7, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-06 2026-11-06 Quarterly Result Announcement NA -8.33%
2026-09-11 2026-09-11 Annual General Meeting NA 6.21%
2026-08-07 2026-08-07 Quarterly Result Announcement NA 4.42%
2026-05-07 2026-05-07 Quarterly Result Announcement NA -2.44%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 2.44%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 0.51%
2025-09-25 2025-09-25 Annual General Meeting NA -0.48%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 2.45%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -4.59%
2025-01-31 2025-01-31 Quarterly Result Announcement NA -2.93%
2024-10-17 2024-10-17 Quarterly Result Announcement NA -6.39%
2024-08-01 2024-08-01 Annual General Meeting NA -4.19%
2023-03-24 2023-03-24 Split 1:10 34.08%
2022-07-21 2022-07-21 Annual General Meeting NA 3.17%

Vivanza Biosciences Competitors Screener - Peer Stocks Comparison

Screen VIVANZA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,531 41.10 61,674 12.69% 11,565 63.60
Divis Laboratories 297,351 90.70 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 179,283 84.50 13,886 20.34% 2,138 47.27
Laurus Labs 123,391 98.10 6,868 22.01% 890 69.60
Zydus Life Science 119,511 27.60 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,804 41.70 35,059 3.90% 4,158 70.24
Cipla 112,486 39.40 29,045 2.24% 3,870 54.92
Mankind Pharma 109,374 48.40 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,529 26.40 34,145 5.56% 3,503 66.06
Lupin 90,932 17.30 29,039 26.75% 5,356 44.92

Vivanza Biosciences Company Announcements - News & Reports Screener

Screen VIVANZA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 11, 2026.

The next most recent announcements are dated November 10, 2026 and November 3, 2026.

Date Update Actions
2026-11-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-10 Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited Held On 06.11.2026 -
2026-11-03 Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Pursuant To Regulation 29 & 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-29 Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations 2015 Regarding Submission Of Disclosures Of Related Party Transactions For The Half Year Ended On September 30 2026 -
2026-10-28 Board Meeting Intimation for Consider And Approve 1. Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-10-08 Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015 -
2026-10-02 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-09-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-12 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-11 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-20 Announcement Under Regulation 30 (LODR)-Newspaper Publication -
2026-08-19 Reg. 34 (1) Annual Report. -
2026-08-19 Notice Of The 44Th Annual General Meeting (AGM) And Annual Report Of The Company For The Financial Year 2025-26 -
2026-08-17 Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026 -
2026-08-12 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-08 Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015 -
2026-08-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company) -
2026-08-07 Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company) -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1.40, within a 52-week range of ₹1.36 to ₹2.40. The P/E ratio is 142.00 and the P/B ratio is 1.22, with earnings per unit of ₹0.10. Market capitalisation stands at ₹5.70 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.